Fadrozole HCL (CGS-16949A) versus megestrol acetate treatment of postmenopausal patients with metastatic breast carcinoma: results of two randomized double blind controlled multiinstitutional trials.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples